321 related articles for article (PubMed ID: 17761972)
1. Brain structure and function differences in monozygotic twins: possible effects of breast cancer chemotherapy.
Ferguson RJ; McDonald BC; Saykin AJ; Ahles TA
J Clin Oncol; 2007 Sep; 25(25):3866-70. PubMed ID: 17761972
[TBL] [Abstract][Full Text] [Related]
2. Neuropsychological functioning in postmenopausal breast cancer patients treated with tamoxifen or exemestane after AC-chemotherapy: cross-sectional findings from the neuropsychological TEAM-side study.
Schilder CM; Eggens PC; Seynaeve C; Linn SC; Boogerd W; Gundy CM; Beex LV; Van Dam FS; Schagen SB
Acta Oncol; 2009; 48(1):76-85. PubMed ID: 18777410
[TBL] [Abstract][Full Text] [Related]
3. Neuropsychological performance in survivors of breast cancer more than 20 years after adjuvant chemotherapy.
Koppelmans V; Breteler MM; Boogerd W; Seynaeve C; Gundy C; Schagen SB
J Clin Oncol; 2012 Apr; 30(10):1080-6. PubMed ID: 22370315
[TBL] [Abstract][Full Text] [Related]
4. Analysis of memory deficits following chemotherapy in breast cancer survivors: evidence from the doors and people test.
Prokasheva S; Faran Y; Cwikel J; Geffen DB
J Psychosoc Oncol; 2011; 29(5):499-514. PubMed ID: 21882931
[TBL] [Abstract][Full Text] [Related]
5. Neurotoxic Effects of Anthracycline- vs Nonanthracycline-Based Chemotherapy on Cognition in Breast Cancer Survivors.
Kesler SR; Blayney DW
JAMA Oncol; 2016 Feb; 2(2):185-92. PubMed ID: 26633037
[TBL] [Abstract][Full Text] [Related]
6. The cognitive sequelae of standard-dose adjuvant chemotherapy in women with breast carcinoma: results of a prospective, randomized, longitudinal trial.
Wefel JS; Lenzi R; Theriault RL; Davis RN; Meyers CA
Cancer; 2004 Jun; 100(11):2292-9. PubMed ID: 15160331
[TBL] [Abstract][Full Text] [Related]
7. Acute and late onset cognitive dysfunction associated with chemotherapy in women with breast cancer.
Wefel JS; Saleeba AK; Buzdar AU; Meyers CA
Cancer; 2010 Jul; 116(14):3348-56. PubMed ID: 20564075
[TBL] [Abstract][Full Text] [Related]
8. The association between neuropsychological impairment, self-perceived cognitive deficits, fatigue and health related quality of life in breast cancer survivors following standard adjuvant versus high-dose chemotherapy.
Mehnert A; Scherwath A; Schirmer L; Schleimer B; Petersen C; Schulz-Kindermann F; Zander AR; Koch U
Patient Educ Couns; 2007 Apr; 66(1):108-18. PubMed ID: 17320337
[TBL] [Abstract][Full Text] [Related]
9. Neuropsychologic impact of standard-dose systemic chemotherapy in long-term survivors of breast cancer and lymphoma.
Ahles TA; Saykin AJ; Furstenberg CT; Cole B; Mott LA; Skalla K; Whedon MB; Bivens S; Mitchell T; Greenberg ER; Silberfarb PM
J Clin Oncol; 2002 Jan; 20(2):485-93. PubMed ID: 11786578
[TBL] [Abstract][Full Text] [Related]
10. Neurocognitive performance in breast cancer survivors exposed to adjuvant chemotherapy and tamoxifen.
Castellon SA; Ganz PA; Bower JE; Petersen L; Abraham L; Greendale GA
J Clin Exp Neuropsychol; 2004 Oct; 26(7):955-69. PubMed ID: 15742545
[TBL] [Abstract][Full Text] [Related]
11. Late effects of high-dose adjuvant chemotherapy on white and gray matter in breast cancer survivors: converging results from multimodal magnetic resonance imaging.
de Ruiter MB; Reneman L; Boogerd W; Veltman DJ; Caan M; Douaud G; Lavini C; Linn SC; Boven E; van Dam FS; Schagen SB
Hum Brain Mapp; 2012 Dec; 33(12):2971-83. PubMed ID: 22095746
[TBL] [Abstract][Full Text] [Related]
12. Selective impairment of attention networks in breast cancer patients receiving chemotherapy treatment.
Chen X; Li J; Ren J; Hu X; Zhu C; Tian Y; Hu P; Ma H; Yu F; Wang K
Psychooncology; 2014 Oct; 23(10):1165-71. PubMed ID: 24737580
[TBL] [Abstract][Full Text] [Related]
13. Cognitive impairment associated with adjuvant therapy in breast cancer.
Bender CM; Sereika SM; Berga SL; Vogel VG; Brufsky AM; Paraska KK; Ryan CM
Psychooncology; 2006 May; 15(5):422-30. PubMed ID: 16097037
[TBL] [Abstract][Full Text] [Related]
14. Cognitive deficits in Korean women treated with chemotherapy for breast cancer.
Jung MS; Cimprich B
Cancer Nurs; 2014; 37(3):E31-42. PubMed ID: 23945143
[TBL] [Abstract][Full Text] [Related]
15. Does tumor necrosis factor-alpha (TNF-α) play a role in post-chemotherapy cerebral dysfunction?
Ganz PA; Bower JE; Kwan L; Castellon SA; Silverman DH; Geist C; Breen EC; Irwin MR; Cole SW
Brain Behav Immun; 2013 Mar; 30 Suppl(Suppl):S99-108. PubMed ID: 22884417
[TBL] [Abstract][Full Text] [Related]
16. Cognitive deficits as long-term side-effects of adjuvant therapy in breast cancer patients: 'subjective' complaints and 'objective' neuropsychological test results.
Weis J; Poppelreuter M; Bartsch HH
Psychooncology; 2009 Jul; 18(7):775-82. PubMed ID: 19061196
[TBL] [Abstract][Full Text] [Related]
17. Longitudinal assessment of chemotherapy-induced alterations in brain activation during multitasking and its relation with cognitive complaints.
Deprez S; Vandenbulcke M; Peeters R; Emsell L; Smeets A; Christiaens MR; Amant F; Sunaert S
J Clin Oncol; 2014 Jul; 32(19):2031-8. PubMed ID: 24868029
[TBL] [Abstract][Full Text] [Related]
18. Cognitive impairment after chemotherapy related to atypical network architecture for executive control.
Piccirillo JF; Hardin FM; Nicklaus J; Kallogjeri D; Wilson M; Ma CX; Coalson RS; Shimony J; Schlaggar BL
Oncology; 2015; 88(6):360-8. PubMed ID: 25678046
[TBL] [Abstract][Full Text] [Related]
19. Chemotherapy and Cognitive Function in Breast Cancer Patients: The So-Called Chemo Brain.
Hermelink K
J Natl Cancer Inst Monogr; 2015 May; 2015(51):67-9. PubMed ID: 26063891
[TBL] [Abstract][Full Text] [Related]
20. The relationship of APOE genotype to neuropsychological performance in long-term cancer survivors treated with standard dose chemotherapy.
Ahles TA; Saykin AJ; Noll WW; Furstenberg CT; Guerin S; Cole B; Mott LA
Psychooncology; 2003 Sep; 12(6):612-9. PubMed ID: 12923801
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
